The Nepal Weekly 
April 29, 2023
A panel in Japan’s health ministry has approved the country’s first abortion pill, in a major step for reproductive rights decades after other countries made abortion medication widely available.
The ministry’s pharmaceutical board granted approval on Friday to the MeFeego Pack, an abortion pill produced by British pharmaceutical Linepharma, informed spokesperson from the Ministry of Health, Labor and Welfare.
The ministry had first convened in January to review the drug, before asking for the public to submit their views through an online portal. It will now go to the health minister for final approval.
The medication consists of two types of pills and can be used within nine weeks of pregnancy, said, Japanese public broadcaster NHK. In a clinical trial in Japan, 93% of participants had a complete abortion within 24 hours, according to NHK.
The medication combines mifepristone and misoprostol, which the World Health Organization has included in its Essential Medicines List, described as safe and effective for pregnant people.
To date, only surgical abortion is available in Japan through two methods: the curettage method, which removes tissue inside the uterus with a metal instrument, and the evacuation method, which sucks out tissue through a tube, according to NHK.
The WHO has described curettage as an “obsolete” method that is less safe and much more painful and has called for it to be replaced by the evacuation method or by medication like abortion pills. The move also comes as abortion and reproductive rights have gained new attention worldwide, with the US Supreme Court reversing overturned Roe v. Wade last year – ruling that there is no longer a federal constitutional right to an abortion.
Since then, many states have restricted access to abortions, while others moved to increase access.
